Cargando…
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
Triple negative breast cancer (TNBC) is a subset of breast cancer that is highly aggressive and has a poor prognosis. Meanwhile, cancer stem cells (CSCs) are also characterized by a strong tumorigenic potential, which might be partly responsible for the aggressive behavior of TNBC. We previously sho...
Autores principales: | Ma, Fei, Li, Huihui, Li, Yiqun, Ding, Xiaoyan, Wang, Haijuan, Fan, Ying, Lin, Chen, Qian, Haili, Xu, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411217/ https://www.ncbi.nlm.nih.gov/pubmed/28383433 http://dx.doi.org/10.1097/MD.0000000000006561 |
Ejemplares similares
-
The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines
por: Guan, Xiuwen, et al.
Publicado: (2016) -
Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer
por: Guan, Xin, et al.
Publicado: (2021) -
Update on the aldehyde dehydrogenase gene (ALDH) superfamily
por: Jackson, Brian, et al.
Publicado: (2011) -
Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer
por: Shen, Jia-Xin, et al.
Publicado: (2016) -
Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)